Last updated on April 18, 2014 at 15:51 EDT

Oncothyreon to Present at Wedbush Securities Life Sciences Management Access Conference

August 6, 2013

SEATTLE, Aug. 6, 2013 /PRNewswire/ – Oncothyreon Inc. (Nasdaq: ONTY) announced
today that Julie Eastland, Chief Financial Officer and Vice President,
Corporate Development, will present at the Wedbush Securities Life
Sciences Management Access Conference in New York on Tuesday, Aug. 13,
2013 at 1:55 p.m. Eastern.

A live and archived webcast of the presentation will be accessible by
visiting the Oncothyreon website www.oncothyreon.com under the “News & Events” section.

About Oncothyreon

Oncothyreon is a biotechnology company specializing in the development
of innovative therapeutic products for the treatment of cancer.
Oncothyreon’s goal is to develop and commercialize novel synthetic
vaccines and targeted small molecules that have the potential to
improve the lives and outcomes of cancer patients. For more
information, visit www.oncothyreon.com.

SOURCE Oncothyreon Inc.

Source: PR Newswire